6401 - 6450 of 8818 Results
Title
Year
-
RESTRICTEDTitle: Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 7Start Page: 1444End Page: 1445Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30247Citation Count: 0
-
OPENTitle: Molecular Insight into Amyloid Fibril-Templated Aggregation of BiomarkersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00103Best OA location URL: https://doi.org/10.1021/acschemneuro.5c00103Citation Count: 0
-
OPENTitle: Cortical complexity alterations in motor subtypes of Parkinson's disease: A surface‐based morphometry analysis of fractal dimensionJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.16612Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16612Citation Count: 0
-
RESTRICTEDTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Best OA location URL: https://link.springer.com/content/pdf/10.1186/s13024-024-00779-9.pdfCitation Count: 9
-
OPENTitle: Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 766End Page: 779Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328567Best OA location URL: https://doi.org/10.1177/1877718x251328567Citation Count: 0
-
OPENTitle: Replication and reliability of Parkinson's disease clinical subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 107016End Page: 107016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016Best OA location URL: http://www.prd-journal.com/article/S1353802024010289/pdfCitation Count: 1
-
OPENTitle: Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCANJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100331End Page: 100331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100331Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100331Citation Count: 1
-
OPENTitle: Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.188413Best OA location URL: http://insight.jci.org/articles/view/188413/files/pdfCitation Count: 0
-
OPENTitle: Regulation of LRRK2 activity by metabolic stress and heavy metal exposureJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1863Issue #:Start Page: 149785End Page: 149785Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2025.149785Best OA location URL: https://doi.org/10.1016/j.brainres.2025.149785Citation Count: 0
-
RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 6
-
RESTRICTEDTitle: The philosophy of Constantine the Philosopher of NicaeaJournal Name: Byzantinische ZeitschriftPublisher: Walter de Gruyter GmbHVol: 114Issue #: 1Start Page: 139End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/bz-2021-9006Citation Count: 0
-
OPENTitle: Supplement (online only): Proceedings of the 14th Göttingen Meeting of the German Neuroscience Society 2021Journal Name: NeuroforumPublisher: Walter de Gruyter GmbHVol: 27Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1515/nf-2021-2003Best OA location URL: https://www.degruyter.com/document/doi/10.1515/nf-2021-2003/pdfCitation Count: 0
-
OPENTitle: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s DiseaseJournal Name: NeurologyPublisher: Touch Medical Media, Ltd.Vol: 17Issue #: 1Start Page: 36End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36Best OA location URL: https://touchneurology.com/wp-content/uploads/sites/3/2021/07/touchNEURO_17.1_pp36-47.pdfCitation Count: 1
-
OPENTitle: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database SubjectsJournal Name: Indiana Health Law ReviewPublisher: IUPUI University LibraryVol: 18Issue #: 1Start Page: 1End Page: 55Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18060/25052Best OA location URL: https://journals.iupui.edu/index.php/ihlr/article/download/25052/23545Citation Count: 3
-
RESTRICTEDTitle: Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and DementiaJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 17Issue #: 13Start Page: 1214End Page: 1220Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210219105949Citation Count: 14
-
OPENTitle: Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic DeficiencyJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 18Issue #: 6Start Page: 499End Page: 504Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210827122133Citation Count: 4
-
RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 0
-
RESTRICTEDTitle: Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and DiscoveryJournal Name: Current Drug Research ReviewsPublisher: Bentham Science Publishers Ltd.Vol: 13Issue #: 2Start Page: 101End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2589977513666210211163711Citation Count: 25
-
OPENTitle: Леводопа/карбідопа пролонгованого вивільнення в лікуванні хвороби ПаркінсонаJournal Name: INTERNATIONAL NEUROLOGICAL JOURNALPublisher: Publishing House ZaslavskyVol:Issue #: 3.97Start Page: 48End Page: 58Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.22141/2224-0713.3.97.2018.133682Best OA location URL: https://inj.zaslavsky.com.ua/index.php/journal/article/download/627/654Citation Count: 0
-
RESTRICTEDTitle: An Overview of the Active Clinical Trials for Parkinson’s Disease PsychosisJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2022-0020Citation Count: 0
-
OPENTitle: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 77End Page: 91Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0057Best OA location URL: https://eprints.ncl.ac.uk/281877Citation Count: 6
-
OPENTitle: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune DisordersJournal Name: Current Chinese ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/2666001601666211126091737Best OA location URL: https://hal.science/hal-03806707Citation Count: 0
-
OPENTitle: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s diseaseJournal Name: Journal of Drug Delivery and TherapeuticsPublisher: Society of Pharmaceutical TecnocratsVol: 11Issue #: 3-SStart Page: 104End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813Best OA location URL: http://jddtonline.info/index.php/jddt/article/download/4813/3895Citation Count: 1
-
OPENTitle: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort StudyJournal Name: Diabetes CarePublisher: American Diabetes AssociationVol: 46Issue #: 2Start Page: 297End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2337/dc22-1705Best OA location URL: https://diabetesjournals.org/care/article-pdf/46/2/297/696578/dc221705.pdfCitation Count: 92
-
OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adn6016Best OA location URL: https://doi.org/10.1126/sciadv.adn6016Citation Count: 8
-
RESTRICTEDTitle: Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequencesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.060159Citation Count: 1
-
OPENTitle: Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1501319Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1501319/pdfCitation Count: 0
-
RESTRICTEDTitle: Agricultural copper pesticide exposure and DNA methylation in Central Valley of California residents with and without Parkinson's diseaseJournal Name: Environmental ResearchPublisher: Elsevier BVVol: 285Issue #:Start Page: 122335End Page: 122335Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envres.2025.122335Best OA location URL: https://doi.org/10.1016/j.envres.2025.122335Citation Count: 0
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 6
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 61Issue #:Start Page: 102765End Page: 102765Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102765Best OA location URL: https://doi.org/10.1016/j.scr.2022.102765Citation Count: 3
-
OPENTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 13
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 23
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 7
-
RESTRICTEDTitle: A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's diseaseJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 77Issue #:Start Page: 238End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2020.04.010Citation Count: 46
- The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegeneration2022RESTRICTEDTitle: The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegenerationJournal Name: Seminars in ImmunologyPublisher: Elsevier BVVol: 61-64Issue #:Start Page: 101655End Page: 101655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smim.2022.101655Citation Count: 3
-
OPENTitle: Closing the structure-to-function gap for LRRK2Journal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 47Issue #: 3Start Page: 187End Page: 188Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003Best OA location URL: http://www.cell.com/article/S0968000421002243/pdfCitation Count: 8
-
OPENTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Citation Count: 3
-
OPENTitle: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation studyJournal Name: Neuroimage: ReportsPublisher: Elsevier BVVol: 1Issue #: 3Start Page: 100026End Page: 100026Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026Best OA location URL: https://doi.org/10.1016/j.ynirp.2021.100026Citation Count: 17
-
RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 9
-
OPENTitle: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 7End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdfCitation Count: 5
-
OPENTitle: Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 16End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.010Best OA location URL: http://www.prd-journal.com/article/S1353802020308609/pdfCitation Count: 42
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
RESTRICTEDTitle: Essential tremor and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 125End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012Citation Count: 3
-
OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 17
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
RESTRICTEDTitle: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 128End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011Citation Count: 0
-
RESTRICTEDTitle: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 66End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004Citation Count: 11
-
OPENTitle: Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.001Citation Count: 9